1. Infective Endocarditis After Transcatheter Aortic Valve Replacement.
- Author
-
Stortecky, Stefan, Heg, Dik, Tueller, David, Pilgrim, Thomas, Muller, Olivier, Noble, Stephane, Jeger, Raban, Toggweiler, Stefan, Ferrari, Enrico, Taramasso, Maurizio, Maisano, Francesco, Hoeller, Rebeca, Wenaweser, Peter, Nietlispach, Fabian, Widmer, Andreas, Huber, Christoph, Roffi, Marco, Carrel, Thierry, Windecker, Stephan, and Conen, Anna
- Subjects
- *
RESEARCH , *RESEARCH methodology , *ENDOCARDITIS , *ACQUISITION of data , *CASE-control method , *DISEASE incidence , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *PROSTHETIC heart valves - Abstract
Background: Infective endocarditis may affect patients after transcatheter aortic valve replacement (TAVR).Objectives: The purpose of this study was to provide detailed information on incidence rates, types of microorganisms, and outcomes of infective endocarditis after TAVR.Methods: Between February 2011 and July 2018, consecutive patients from the SwissTAVI Registry were eligible. Infective endocarditis was classified into early (peri-procedural [<100 days] and delayed-early [100 days to 1 year]) and late (>1 year) endocarditis. Clinical events were adjudicated according to the Valve Academic Research Consortium-2 endpoint definitions.Results: During the observational period, 7,203 patients underwent TAVR at 15 hospitals in Switzerland. During follow-up of 14,832 patient-years, endocarditis occurred in 149 patients. The incidence for peri-procedural, delayed-early, and late endocarditis after TAVR was 2.59, 0.71, and 0.40 events per 100 person-years, respectively. Among patients with early endocarditis, Enterococcus species were the most frequently isolated microorganisms (30.1%). Among those with peri-procedural endocarditis, 47.9% of patients had a pathogen that was not susceptible to the peri-procedural antibiotic prophylaxis. Younger age (subhazard ratio [SHR]: 0.969; 95% confidence interval [CI]: 0.944 to 0.994), male sex (SHR: 1.989; 95% CI: 1.403 to 2.818), lack of pre-dilatation (SHR: 1.485; 95% CI: 1.065 to 2.069), and treatment in a catheterization laboratory as opposed to hybrid operating room (SHR: 1.648; 95% CI: 1.187 to 2.287) were independently associated with endocarditis. In a case-control matched analysis, patients with endocarditis were at increased risk of mortality (hazard ratio: 6.55; 95% CI: 4.44 to 9.67) and stroke (hazard ratio: 4.03; 95% CI: 1.54 to 10.52).Conclusions: Infective endocarditis after TAVR most frequently occurs during the early period, is commonly caused by Enterococcus species, and results in considerable risks of mortality and stroke. (NCT01368250). [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF